Overview
- 4 inspections across 4 sites are on record.
- 3 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2017-06-07.
At a glance
Inspections
4
Sites
4
Observations
3
Career since
Mar 2009
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| NEOLPHARMA, INC. | 7 Jun 2017 | Human Drugs | On file |
| Abbott Healthcare (Puerto Rico) Ltd. | 29 Jul 2016 | Human Drugs | On file |
| Abbvie LTD | 29 Jul 2016 | Human Drugs | On file |
| Pfizer Pharmaceuticals LLC | 19 Mar 2009 | On file |
Sites inspected
NEOLPHARMA, INC.Caguas, United States1 insp.
Abbott Healthcare (Puerto Rico) Ltd.Barceloneta, United States1 insp.
Abbvie LTDBarceloneta, United States1 insp.
Pfizer Pharmaceuticals LLCCaguas, United States1 insp.
Co-investigators
Investigators who share inspections with this person.
Full investigator report
Get the verbatim findings behind Rebeca M Melendez's 3 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site